Skip to Main content
Home > Providers > Quality improvement > Clinical practice guidelines
A default font size | A medium font size | A large font size Text size

Clinical Practice Guidelines

The Quality Improvement/Utilization Management Committee (QI/UM) delegates responsibility for the evaluation of clinical practice guidelines (CPG) to the Provider Advisory Committee (PAC). All the materials on this page, including CPG, condensed versions, Guideline Watch, executive summaries, and TIPS, were readopted by the PAC on March 6, 2018.

Assessment and treatment of patients with suicidal behaviors

Adapted from the American Academy of Pediatrics

Attention deficit hyperactivity disorder (ADHD)

Adapted from the American Academy of Pediatrics

Bipolar disorder

Adapted from the American Psychiatric Association

This guideline is more than five years old and has not yet been updated to ensure that it reflects current knowledge and practice. In accordance with national standards, including those of the Agency for Healthcare Research and Quality National Guideline Clearinghouse, this guideline can no longer be assumed to be current. A third edition of this guideline is in development. The November 2005 Guideline Watch associated with this guideline provides additional information that has become available since publication of the guideline, but it is not a formal update of the guideline.

Bipolar disorder in children and adolescents

Adapted from the American Academy of Child and Adolescent Psychiatry

Family-based mental health services (FBMHS)

The Family-Based Mental Health Practice Guidelines (FBPG) (PDF) is the product of a workgroup that consists of consumers, providers, county stakeholders, the Capital Area Behavioral Health Collaborative, and PerformCare. These guidelines are intended to serve four purposes:

  • To improve FBMHS service outcomes for members and their families.
  • To increase the coherence and consistency of service delivery in the practice of conducting FBMHS.
  • To promote continuous quality improvement and best utilization management practices associated with the service delivery of FBMHS.
  • To provide a common understanding of the FBMHS level of care and the practice standards within a behavioral health managed care environment.

This FBPG will clarify PerformCare's expectations for providers of FBMHS and serve as a basis for monitoring the quality of FBMHS treatment and programs in the PerformCare provider network. Please note that although the FBPG were designed in compliance with relevant regulation, the FBPG are guidelines adopted by PerformCare and not to be interpreted as statutory or regulatory. These documents should be the basis for FBMHS practice and for the staff delivering these services who should be familiar with these regulations. PerformCare implemented these guidelines in November 2015.

Major depressive disorder

Adapted from the American Psychiatric Association

Oppositional defiant disorder

Adapted from the American Academy of Child and Adolescent Psychiatry

Posttraumatic stress disorder (PTSD)

Adapted from the American Psychological Association

Psychiatric evaluation of adults

Adapted from the American Psychiatric Association

Schizophrenia

Adapted from the American Psychiatric Association

This guideline is more than five years old and has not yet been updated to ensure that it reflects current knowledge and practice. In accordance with national standards, including those of the Agency for Healthcare Research and Quality National Guideline Clearinghouse, this guideline can no longer be assumed to be current. The November 2009 Guideline Watch associated with this guideline provides additional information that has become available since publication of the guideline, but it is not a formal update of the guideline.

Substance use disorders (SUD)

Adapted from the American Psychiatric Association

This guideline is more than five years old and has not yet been updated to ensure that it reflects current knowledge and practice. In accordance with national standards, including those of the Agency for Healthcare Research and Quality National Guideline Clearinghouse, this guideline can no longer be assumed to be current. The April 2007 Guideline Watch associated with this guideline provides additional information that has become available since publication of the guideline, but it is not a formal update of the guideline.